Sign in
CANF Stock Price, Chart, Stats & News
Can-Fite BioPharma Ltd.
Save
Can-Fite BioPharma Ltd. (CANF) does not currently pay a dividend.
–
Market cap
–
Current P/E
2.97x
Forward P/E
CANF chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 100.00% |
Operating margin | -1595.36% |
Pretax margin | -1571.25% |
Net margin | -1571.25% |
Effective tax rate | – |
ROA | -113.98% |
ROE | -182.93% |
D/E | 0.02x |
Interest coverage ratio | – |
CANF valuation
P/E | – |
P/S | 3.02x |
P/B | 8.54x |
P/CF | -4.28x |
P/FCF | -0.20x |
P/OCF | -4.28x |
PEG | -0.35x |
EV multiple | -0.90x |
About
Can-Fite BioPharma Ltd., an Israeli clinical-stage biopharmaceutical company, specializes in the creation of small molecule therapeutic products. These treatments target a range of conditions including various cancers, inflammatory liver disorders, and erectile dysfunction. Its primary drug candidate, Piclidenoson, has successfully advanced through Phase III clinical trials for psoriasis and completed Phase II trials for COVID-19.
Similar securities
Based on sector and market capitalization
Report issue